PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Toxicology of School of Public Health and Department of Gynecologic Oncology of Women\'s Hospital, School of Medicine, Zhejiang University, Hangzhou 310058, China.\', \'The State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.\', \'Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou 310003, China.\', \'National Clinical Research Center for Infectious Diseases, Hangzhou 310003, China.\', \'Department of Toxicology of School of Public Health and Department of Gynecologic Oncology of Women\'s Hospital, School of Medicine, Zhejiang University, Hangzhou 310058, China. dxia@zju.edu.cn.\', \'Department of Toxicology of School of Public Health and Department of Gynecologic Oncology of Women\'s Hospital, School of Medicine, Zhejiang University, Hangzhou 310058, China. georgewu@zju.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 1673-1581(2021)10-0876-0910.1631/jzus.B2100151
?:doi
?:hasPublicationType
?:journal
  • Journal of Zhejiang University. Science. B
is ?:pmid of
?:pmid
?:pmid
  • 34636190
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of antitumor regimens on the outcomes of cancer patients with COVID-19: a pooled analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all